nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C8—Salmeterol—asthma	0.0324	0.0453	CbGbCtD
Levomilnacipran—CYP2C8—Mometasone—asthma	0.0324	0.0453	CbGbCtD
Levomilnacipran—ABCB1—Fluticasone furoate—asthma	0.0289	0.0405	CbGbCtD
Levomilnacipran—CYP2C8—Zafirlukast—asthma	0.0254	0.0356	CbGbCtD
Levomilnacipran—ABCB1—Indacaterol—asthma	0.0236	0.033	CbGbCtD
Levomilnacipran—CYP2D6—Ciclesonide—asthma	0.0222	0.0311	CbGbCtD
Levomilnacipran—CYP2C19—Zafirlukast—asthma	0.0213	0.0299	CbGbCtD
Levomilnacipran—CYP2C19—Arformoterol—asthma	0.0206	0.0288	CbGbCtD
Levomilnacipran—CYP2C19—Formoterol—asthma	0.0206	0.0288	CbGbCtD
Levomilnacipran—CYP2C8—Theophylline—asthma	0.0196	0.0275	CbGbCtD
Levomilnacipran—CYP2C8—Loratadine—asthma	0.0186	0.026	CbGbCtD
Levomilnacipran—CYP2C8—Montelukast—asthma	0.0186	0.026	CbGbCtD
Levomilnacipran—CYP2D6—Ipratropium bromide—asthma	0.0184	0.0258	CbGbCtD
Levomilnacipran—CYP3A4—Fluticasone furoate—asthma	0.0173	0.0243	CbGbCtD
Levomilnacipran—CYP2D6—Zafirlukast—asthma	0.0162	0.0227	CbGbCtD
Levomilnacipran—CYP2D6—Arformoterol—asthma	0.0157	0.0219	CbGbCtD
Levomilnacipran—CYP2D6—Formoterol—asthma	0.0157	0.0219	CbGbCtD
Levomilnacipran—CYP2C19—Loratadine—asthma	0.0156	0.0218	CbGbCtD
Levomilnacipran—CYP3A4—Budesonide—asthma	0.0155	0.0216	CbGbCtD
Levomilnacipran—CYP3A4—Indacaterol—asthma	0.0141	0.0198	CbGbCtD
Levomilnacipran—CYP3A4—Ciclesonide—asthma	0.0141	0.0198	CbGbCtD
Levomilnacipran—CYP2D6—Tiotropium—asthma	0.014	0.0195	CbGbCtD
Levomilnacipran—CYP3A4—Salbutamol—asthma	0.0131	0.0184	CbGbCtD
Levomilnacipran—CYP3A4—Flunisolide—asthma	0.0131	0.0184	CbGbCtD
Levomilnacipran—CYP3A4—Salmeterol—asthma	0.0131	0.0184	CbGbCtD
Levomilnacipran—ABCB1—Loratadine—asthma	0.0126	0.0176	CbGbCtD
Levomilnacipran—CYP2D6—Theophylline—asthma	0.0125	0.0175	CbGbCtD
Levomilnacipran—CYP2D6—Loratadine—asthma	0.0119	0.0166	CbGbCtD
Levomilnacipran—CYP3A4—Ipratropium bromide—asthma	0.0117	0.0164	CbGbCtD
Levomilnacipran—CYP3A4—Zileuton—asthma	0.0117	0.0164	CbGbCtD
Levomilnacipran—ABCB1—Methylprednisolone—asthma	0.0115	0.0161	CbGbCtD
Levomilnacipran—CYP3A4—Fluticasone Propionate—asthma	0.0112	0.0156	CbGbCtD
Levomilnacipran—CYP2C8—Hydrocortisone—asthma	0.0104	0.0145	CbGbCtD
Levomilnacipran—CYP3A4—Zafirlukast—asthma	0.0103	0.0144	CbGbCtD
Levomilnacipran—CYP3A4—Tiotropium—asthma	0.00888	0.0124	CbGbCtD
Levomilnacipran—CYP2C19—Prednisone—asthma	0.00865	0.0121	CbGbCtD
Levomilnacipran—CYP3A4—Aminophylline—asthma	0.00847	0.0119	CbGbCtD
Levomilnacipran—CYP3A4—Theophylline—asthma	0.00796	0.0111	CbGbCtD
Levomilnacipran—CYP3A4—Montelukast—asthma	0.00755	0.0106	CbGbCtD
Levomilnacipran—CYP3A4—Loratadine—asthma	0.00755	0.0106	CbGbCtD
Levomilnacipran—ABCB1—Betamethasone—asthma	0.00749	0.0105	CbGbCtD
Levomilnacipran—ABCB1—Prednisolone—asthma	0.00739	0.0103	CbGbCtD
Levomilnacipran—ABCB1—Hydrocortisone—asthma	0.00701	0.00981	CbGbCtD
Levomilnacipran—ABCB1—Prednisone—asthma	0.00698	0.00977	CbGbCtD
Levomilnacipran—CYP3A4—Methylprednisolone—asthma	0.0069	0.00966	CbGbCtD
Levomilnacipran—CYP2C8—Dexamethasone—asthma	0.00644	0.00901	CbGbCtD
Levomilnacipran—CYP2C19—Dexamethasone—asthma	0.0054	0.00756	CbGbCtD
Levomilnacipran—CYP3A4—Triamcinolone—asthma	0.00523	0.00732	CbGbCtD
Levomilnacipran—CYP3A4—Betamethasone—asthma	0.00449	0.00628	CbGbCtD
Levomilnacipran—CYP3A4—Prednisolone—asthma	0.00443	0.0062	CbGbCtD
Levomilnacipran—ABCB1—Dexamethasone—asthma	0.00436	0.0061	CbGbCtD
Levomilnacipran—CYP3A4—Hydrocortisone—asthma	0.0042	0.00588	CbGbCtD
Levomilnacipran—CYP3A4—Prednisone—asthma	0.00418	0.00585	CbGbCtD
Levomilnacipran—CYP2D6—Dexamethasone—asthma	0.00411	0.00575	CbGbCtD
Levomilnacipran—CYP3A4—Dexamethasone—asthma	0.00261	0.00365	CbGbCtD
Levomilnacipran—SLC6A2—autonomic nervous system—asthma	0.000761	0.245	CbGeAlD
Levomilnacipran—CYP2J2—bronchus—asthma	0.00034	0.109	CbGeAlD
Levomilnacipran—CYP2J2—cardiovascular system—asthma	0.000316	0.102	CbGeAlD
Levomilnacipran—CYP2J2—trachea—asthma	0.000305	0.0981	CbGeAlD
Levomilnacipran—SLC6A4—respiratory system—asthma	0.000222	0.0715	CbGeAlD
Levomilnacipran—CYP2J2—lung—asthma	0.000219	0.0705	CbGeAlD
Levomilnacipran—SLC6A2—respiratory system—asthma	0.000196	0.063	CbGeAlD
Levomilnacipran—SLC6A2—adrenal gland—asthma	0.000119	0.0382	CbGeAlD
Levomilnacipran—SLC6A4—lung—asthma	0.000118	0.038	CbGeAlD
Levomilnacipran—SLC6A2—lung—asthma	0.000104	0.0334	CbGeAlD
Levomilnacipran—Hallucination—Dexamethasone—asthma	8.23e-05	0.000344	CcSEcCtD
Levomilnacipran—Hallucination—Betamethasone—asthma	8.23e-05	0.000344	CcSEcCtD
Levomilnacipran—Nausea—Mometasone—asthma	8.23e-05	0.000344	CcSEcCtD
Levomilnacipran—Rash—Arformoterol—asthma	8.2e-05	0.000342	CcSEcCtD
Levomilnacipran—Rash—Formoterol—asthma	8.2e-05	0.000342	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Methylprednisolone—asthma	8.2e-05	0.000342	CcSEcCtD
Levomilnacipran—Dermatitis—Arformoterol—asthma	8.19e-05	0.000342	CcSEcCtD
Levomilnacipran—Dermatitis—Formoterol—asthma	8.19e-05	0.000342	CcSEcCtD
Levomilnacipran—Headache—Formoterol—asthma	8.15e-05	0.00034	CcSEcCtD
Levomilnacipran—Headache—Arformoterol—asthma	8.15e-05	0.00034	CcSEcCtD
Levomilnacipran—Weight decreased—Prednisone—asthma	8.14e-05	0.00034	CcSEcCtD
Levomilnacipran—Diarrhoea—Budesonide—asthma	8.14e-05	0.00034	CcSEcCtD
Levomilnacipran—Vision blurred—Prednisolone—asthma	8.13e-05	0.00034	CcSEcCtD
Levomilnacipran—Dizziness—Salbutamol—asthma	8.12e-05	0.000339	CcSEcCtD
Levomilnacipran—Vomiting—Montelukast—asthma	8.1e-05	0.000338	CcSEcCtD
Levomilnacipran—Rash—Montelukast—asthma	8.03e-05	0.000335	CcSEcCtD
Levomilnacipran—Dermatitis—Montelukast—asthma	8.02e-05	0.000335	CcSEcCtD
Levomilnacipran—Headache—Montelukast—asthma	7.98e-05	0.000333	CcSEcCtD
Levomilnacipran—Mental disorder—Methylprednisolone—asthma	7.97e-05	0.000333	CcSEcCtD
Levomilnacipran—Malnutrition—Methylprednisolone—asthma	7.92e-05	0.000331	CcSEcCtD
Levomilnacipran—Dizziness—Budesonide—asthma	7.86e-05	0.000328	CcSEcCtD
Levomilnacipran—Vomiting—Salbutamol—asthma	7.81e-05	0.000326	CcSEcCtD
Levomilnacipran—Dysgeusia—Triamcinolone—asthma	7.77e-05	0.000324	CcSEcCtD
Levomilnacipran—Rash—Salbutamol—asthma	7.74e-05	0.000323	CcSEcCtD
Levomilnacipran—Syncope—Prednisolone—asthma	7.74e-05	0.000323	CcSEcCtD
Levomilnacipran—Dermatitis—Salbutamol—asthma	7.73e-05	0.000323	CcSEcCtD
Levomilnacipran—Eye disorder—Betamethasone—asthma	7.73e-05	0.000323	CcSEcCtD
Levomilnacipran—Eye disorder—Dexamethasone—asthma	7.73e-05	0.000323	CcSEcCtD
Levomilnacipran—Nausea—Arformoterol—asthma	7.72e-05	0.000323	CcSEcCtD
Levomilnacipran—Nausea—Formoterol—asthma	7.72e-05	0.000323	CcSEcCtD
Levomilnacipran—ABCB1—respiratory system—asthma	7.71e-05	0.0248	CbGeAlD
Levomilnacipran—Headache—Salbutamol—asthma	7.69e-05	0.000321	CcSEcCtD
Levomilnacipran—Loss of consciousness—Prednisolone—asthma	7.58e-05	0.000317	CcSEcCtD
Levomilnacipran—Nausea—Montelukast—asthma	7.57e-05	0.000316	CcSEcCtD
Levomilnacipran—Vomiting—Budesonide—asthma	7.56e-05	0.000316	CcSEcCtD
Levomilnacipran—Syncope—Hydrocortisone—asthma	7.56e-05	0.000316	CcSEcCtD
Levomilnacipran—Angiopathy—Betamethasone—asthma	7.5e-05	0.000313	CcSEcCtD
Levomilnacipran—Angiopathy—Dexamethasone—asthma	7.5e-05	0.000313	CcSEcCtD
Levomilnacipran—Rash—Budesonide—asthma	7.5e-05	0.000313	CcSEcCtD
Levomilnacipran—Dermatitis—Budesonide—asthma	7.49e-05	0.000313	CcSEcCtD
Levomilnacipran—Convulsion—Prednisolone—asthma	7.48e-05	0.000312	CcSEcCtD
Levomilnacipran—Headache—Budesonide—asthma	7.45e-05	0.000311	CcSEcCtD
Levomilnacipran—Hypertension—Prednisolone—asthma	7.45e-05	0.000311	CcSEcCtD
Levomilnacipran—Loss of consciousness—Hydrocortisone—asthma	7.41e-05	0.000309	CcSEcCtD
Levomilnacipran—Convulsion—Hydrocortisone—asthma	7.3e-05	0.000305	CcSEcCtD
Levomilnacipran—Nausea—Salbutamol—asthma	7.29e-05	0.000305	CcSEcCtD
Levomilnacipran—Hypertension—Hydrocortisone—asthma	7.28e-05	0.000304	CcSEcCtD
Levomilnacipran—Hallucination—Prednisone—asthma	7.17e-05	0.000299	CcSEcCtD
Levomilnacipran—Anxiety—Hydrocortisone—asthma	7.15e-05	0.000299	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	7.13e-05	0.000298	CcSEcCtD
Levomilnacipran—Syncope—Triamcinolone—asthma	7.12e-05	0.000297	CcSEcCtD
Levomilnacipran—Syncope—Methylprednisolone—asthma	7.1e-05	0.000296	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Prednisone—asthma	7.08e-05	0.000296	CcSEcCtD
Levomilnacipran—Nausea—Budesonide—asthma	7.06e-05	0.000295	CcSEcCtD
Levomilnacipran—Loss of consciousness—Triamcinolone—asthma	6.97e-05	0.000291	CcSEcCtD
Levomilnacipran—Loss of consciousness—Methylprednisolone—asthma	6.96e-05	0.000291	CcSEcCtD
Levomilnacipran—Shock—Prednisolone—asthma	6.93e-05	0.000289	CcSEcCtD
Levomilnacipran—Convulsion—Triamcinolone—asthma	6.88e-05	0.000287	CcSEcCtD
Levomilnacipran—Tachycardia—Prednisolone—asthma	6.87e-05	0.000287	CcSEcCtD
Levomilnacipran—Convulsion—Methylprednisolone—asthma	6.86e-05	0.000286	CcSEcCtD
Levomilnacipran—Hypertension—Triamcinolone—asthma	6.85e-05	0.000286	CcSEcCtD
Levomilnacipran—Hypertension—Methylprednisolone—asthma	6.84e-05	0.000285	CcSEcCtD
Levomilnacipran—Infection—Hydrocortisone—asthma	6.83e-05	0.000285	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Prednisolone—asthma	6.81e-05	0.000284	CcSEcCtD
Levomilnacipran—Shock—Hydrocortisone—asthma	6.77e-05	0.000283	CcSEcCtD
Levomilnacipran—Nervous system disorder—Hydrocortisone—asthma	6.74e-05	0.000282	CcSEcCtD
Levomilnacipran—Eye disorder—Prednisone—asthma	6.73e-05	0.000281	CcSEcCtD
Levomilnacipran—Anxiety—Methylprednisolone—asthma	6.72e-05	0.00028	CcSEcCtD
Levomilnacipran—Tachycardia—Hydrocortisone—asthma	6.71e-05	0.00028	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.69e-05	0.00028	CcSEcCtD
Levomilnacipran—Flushing—Prednisone—asthma	6.68e-05	0.000279	CcSEcCtD
Levomilnacipran—Skin disorder—Hydrocortisone—asthma	6.68e-05	0.000279	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Hydrocortisone—asthma	6.65e-05	0.000278	CcSEcCtD
Levomilnacipran—Dry mouth—Triamcinolone—asthma	6.61e-05	0.000276	CcSEcCtD
Levomilnacipran—Anorexia—Hydrocortisone—asthma	6.56e-05	0.000274	CcSEcCtD
Levomilnacipran—Angiopathy—Prednisone—asthma	6.53e-05	0.000273	CcSEcCtD
Levomilnacipran—ABCB1—adrenal cortex—asthma	6.47e-05	0.0208	CbGeAlD
Levomilnacipran—Syncope—Dexamethasone—asthma	6.46e-05	0.00027	CcSEcCtD
Levomilnacipran—Syncope—Betamethasone—asthma	6.46e-05	0.00027	CcSEcCtD
Levomilnacipran—ABCB1—epithelium—asthma	6.45e-05	0.0207	CbGeAlD
Levomilnacipran—Infection—Triamcinolone—asthma	6.43e-05	0.000269	CcSEcCtD
Levomilnacipran—Hypotension—Hydrocortisone—asthma	6.43e-05	0.000268	CcSEcCtD
Levomilnacipran—Infection—Methylprednisolone—asthma	6.42e-05	0.000268	CcSEcCtD
Levomilnacipran—Shock—Triamcinolone—asthma	6.37e-05	0.000266	CcSEcCtD
Levomilnacipran—Insomnia—Prednisolone—asthma	6.37e-05	0.000266	CcSEcCtD
Levomilnacipran—Shock—Methylprednisolone—asthma	6.36e-05	0.000265	CcSEcCtD
Levomilnacipran—Nervous system disorder—Methylprednisolone—asthma	6.34e-05	0.000265	CcSEcCtD
Levomilnacipran—Loss of consciousness—Dexamethasone—asthma	6.33e-05	0.000264	CcSEcCtD
Levomilnacipran—Loss of consciousness—Betamethasone—asthma	6.33e-05	0.000264	CcSEcCtD
Levomilnacipran—Paraesthesia—Prednisolone—asthma	6.32e-05	0.000264	CcSEcCtD
Levomilnacipran—Tachycardia—Triamcinolone—asthma	6.32e-05	0.000264	CcSEcCtD
Levomilnacipran—Mental disorder—Prednisone—asthma	6.31e-05	0.000264	CcSEcCtD
Levomilnacipran—Tachycardia—Methylprednisolone—asthma	6.31e-05	0.000263	CcSEcCtD
Levomilnacipran—Skin disorder—Methylprednisolone—asthma	6.28e-05	0.000262	CcSEcCtD
Levomilnacipran—Malnutrition—Prednisone—asthma	6.27e-05	0.000262	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Triamcinolone—asthma	6.26e-05	0.000261	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Methylprednisolone—asthma	6.25e-05	0.000261	CcSEcCtD
Levomilnacipran—Convulsion—Betamethasone—asthma	6.24e-05	0.00026	CcSEcCtD
Levomilnacipran—Convulsion—Dexamethasone—asthma	6.24e-05	0.00026	CcSEcCtD
Levomilnacipran—Insomnia—Hydrocortisone—asthma	6.22e-05	0.00026	CcSEcCtD
Levomilnacipran—Hypertension—Dexamethasone—asthma	6.22e-05	0.00026	CcSEcCtD
Levomilnacipran—Hypertension—Betamethasone—asthma	6.22e-05	0.00026	CcSEcCtD
Levomilnacipran—Paraesthesia—Hydrocortisone—asthma	6.18e-05	0.000258	CcSEcCtD
Levomilnacipran—Anxiety—Betamethasone—asthma	6.11e-05	0.000255	CcSEcCtD
Levomilnacipran—Anxiety—Dexamethasone—asthma	6.11e-05	0.000255	CcSEcCtD
Levomilnacipran—Dyspepsia—Hydrocortisone—asthma	6.05e-05	0.000253	CcSEcCtD
Levomilnacipran—Hypotension—Methylprednisolone—asthma	6.04e-05	0.000252	CcSEcCtD
Levomilnacipran—Decreased appetite—Hydrocortisone—asthma	5.98e-05	0.00025	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Hydrocortisone—asthma	5.94e-05	0.000248	CcSEcCtD
Levomilnacipran—Fatigue—Hydrocortisone—asthma	5.93e-05	0.000248	CcSEcCtD
Levomilnacipran—Vision blurred—Prednisone—asthma	5.91e-05	0.000247	CcSEcCtD
Levomilnacipran—ABCB1—cardiovascular system—asthma	5.91e-05	0.019	CbGeAlD
Levomilnacipran—Insomnia—Triamcinolone—asthma	5.86e-05	0.000245	CcSEcCtD
Levomilnacipran—Insomnia—Methylprednisolone—asthma	5.84e-05	0.000244	CcSEcCtD
Levomilnacipran—Infection—Dexamethasone—asthma	5.84e-05	0.000244	CcSEcCtD
Levomilnacipran—Infection—Betamethasone—asthma	5.84e-05	0.000244	CcSEcCtD
Levomilnacipran—Paraesthesia—Triamcinolone—asthma	5.82e-05	0.000243	CcSEcCtD
Levomilnacipran—Paraesthesia—Methylprednisolone—asthma	5.8e-05	0.000242	CcSEcCtD
Levomilnacipran—Shock—Dexamethasone—asthma	5.78e-05	0.000241	CcSEcCtD
Levomilnacipran—Shock—Betamethasone—asthma	5.78e-05	0.000241	CcSEcCtD
Levomilnacipran—Dyspnoea—Triamcinolone—asthma	5.77e-05	0.000241	CcSEcCtD
Levomilnacipran—Nervous system disorder—Dexamethasone—asthma	5.76e-05	0.000241	CcSEcCtD
Levomilnacipran—Nervous system disorder—Betamethasone—asthma	5.76e-05	0.000241	CcSEcCtD
Levomilnacipran—Agitation—Prednisone—asthma	5.76e-05	0.000241	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Betamethasone—asthma	5.75e-05	0.00024	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Dexamethasone—asthma	5.75e-05	0.00024	CcSEcCtD
Levomilnacipran—Tachycardia—Betamethasone—asthma	5.73e-05	0.000239	CcSEcCtD
Levomilnacipran—Tachycardia—Dexamethasone—asthma	5.73e-05	0.000239	CcSEcCtD
Levomilnacipran—Dyspepsia—Triamcinolone—asthma	5.7e-05	0.000238	CcSEcCtD
Levomilnacipran—ABCB1—trachea—asthma	5.7e-05	0.0183	CbGeAlD
Levomilnacipran—Dyspepsia—Methylprednisolone—asthma	5.69e-05	0.000238	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Dexamethasone—asthma	5.68e-05	0.000237	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Betamethasone—asthma	5.68e-05	0.000237	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Hydrocortisone—asthma	5.62e-05	0.000235	CcSEcCtD
Levomilnacipran—Syncope—Prednisone—asthma	5.62e-05	0.000235	CcSEcCtD
Levomilnacipran—Anorexia—Dexamethasone—asthma	5.6e-05	0.000234	CcSEcCtD
Levomilnacipran—Anorexia—Betamethasone—asthma	5.6e-05	0.000234	CcSEcCtD
Levomilnacipran—Urticaria—Prednisolone—asthma	5.59e-05	0.000234	CcSEcCtD
Levomilnacipran—Fatigue—Triamcinolone—asthma	5.58e-05	0.000233	CcSEcCtD
Levomilnacipran—Fatigue—Methylprednisolone—asthma	5.57e-05	0.000233	CcSEcCtD
Levomilnacipran—Loss of consciousness—Prednisone—asthma	5.51e-05	0.00023	CcSEcCtD
Levomilnacipran—Hypotension—Betamethasone—asthma	5.49e-05	0.000229	CcSEcCtD
Levomilnacipran—Hypotension—Dexamethasone—asthma	5.49e-05	0.000229	CcSEcCtD
Levomilnacipran—Urticaria—Hydrocortisone—asthma	5.46e-05	0.000228	CcSEcCtD
Levomilnacipran—Abdominal pain—Hydrocortisone—asthma	5.44e-05	0.000227	CcSEcCtD
Levomilnacipran—Body temperature increased—Hydrocortisone—asthma	5.44e-05	0.000227	CcSEcCtD
Levomilnacipran—Convulsion—Prednisone—asthma	5.43e-05	0.000227	CcSEcCtD
Levomilnacipran—Hypertension—Prednisone—asthma	5.41e-05	0.000226	CcSEcCtD
Levomilnacipran—Anxiety—Prednisone—asthma	5.32e-05	0.000222	CcSEcCtD
Levomilnacipran—Insomnia—Betamethasone—asthma	5.31e-05	0.000222	CcSEcCtD
Levomilnacipran—Insomnia—Dexamethasone—asthma	5.31e-05	0.000222	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	5.3e-05	0.000221	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Methylprednisolone—asthma	5.28e-05	0.000221	CcSEcCtD
Levomilnacipran—Paraesthesia—Dexamethasone—asthma	5.28e-05	0.00022	CcSEcCtD
Levomilnacipran—Paraesthesia—Betamethasone—asthma	5.28e-05	0.00022	CcSEcCtD
Levomilnacipran—Hypersensitivity—Prednisolone—asthma	5.19e-05	0.000217	CcSEcCtD
Levomilnacipran—Dyspepsia—Dexamethasone—asthma	5.17e-05	0.000216	CcSEcCtD
Levomilnacipran—Dyspepsia—Betamethasone—asthma	5.17e-05	0.000216	CcSEcCtD
Levomilnacipran—Urticaria—Triamcinolone—asthma	5.14e-05	0.000215	CcSEcCtD
Levomilnacipran—Urticaria—Methylprednisolone—asthma	5.13e-05	0.000214	CcSEcCtD
Levomilnacipran—Body temperature increased—Triamcinolone—asthma	5.12e-05	0.000214	CcSEcCtD
Levomilnacipran—Abdominal pain—Methylprednisolone—asthma	5.11e-05	0.000213	CcSEcCtD
Levomilnacipran—Decreased appetite—Dexamethasone—asthma	5.11e-05	0.000213	CcSEcCtD
Levomilnacipran—Decreased appetite—Betamethasone—asthma	5.11e-05	0.000213	CcSEcCtD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-DRB1—asthma	5.08e-05	0.00119	CbGpPWpGaD
Levomilnacipran—Infection—Prednisone—asthma	5.08e-05	0.000212	CcSEcCtD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—asthma	5.07e-05	0.00119	CbGpPWpGaD
Levomilnacipran—Gastrointestinal disorder—Dexamethasone—asthma	5.07e-05	0.000212	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Betamethasone—asthma	5.07e-05	0.000212	CcSEcCtD
Levomilnacipran—Hypersensitivity—Hydrocortisone—asthma	5.07e-05	0.000212	CcSEcCtD
Levomilnacipran—Fatigue—Betamethasone—asthma	5.07e-05	0.000212	CcSEcCtD
Levomilnacipran—Fatigue—Dexamethasone—asthma	5.07e-05	0.000212	CcSEcCtD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—asthma	5.05e-05	0.00118	CbGpPWpGaD
Levomilnacipran—Shock—Prednisone—asthma	5.03e-05	0.00021	CcSEcCtD
Levomilnacipran—Nervous system disorder—Prednisone—asthma	5.02e-05	0.00021	CcSEcCtD
Levomilnacipran—CYP2D6—Biological oxidations—GSTT1—asthma	5.01e-05	0.00118	CbGpPWpGaD
Levomilnacipran—Tachycardia—Prednisone—asthma	4.99e-05	0.000209	CcSEcCtD
Levomilnacipran—Skin disorder—Prednisone—asthma	4.97e-05	0.000208	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Prednisone—asthma	4.95e-05	0.000207	CcSEcCtD
Levomilnacipran—Asthenia—Hydrocortisone—asthma	4.93e-05	0.000206	CcSEcCtD
Levomilnacipran—Anorexia—Prednisone—asthma	4.88e-05	0.000204	CcSEcCtD
Levomilnacipran—Pruritus—Hydrocortisone—asthma	4.87e-05	0.000203	CcSEcCtD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—CARM1—asthma	4.84e-05	0.00113	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALOX5—asthma	4.81e-05	0.00113	CbGpPWpGaD
Levomilnacipran—Gastrointestinal pain—Betamethasone—asthma	4.8e-05	0.000201	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Dexamethasone—asthma	4.8e-05	0.000201	CcSEcCtD
Levomilnacipran—Hypersensitivity—Triamcinolone—asthma	4.77e-05	0.000199	CcSEcCtD
Levomilnacipran—Hypersensitivity—Methylprednisolone—asthma	4.76e-05	0.000199	CcSEcCtD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—asthma	4.71e-05	0.0011	CbGpPWpGaD
Levomilnacipran—Diarrhoea—Hydrocortisone—asthma	4.71e-05	0.000197	CcSEcCtD
Levomilnacipran—ABCB1—adrenal gland—asthma	4.67e-05	0.015	CbGeAlD
Levomilnacipran—Urticaria—Dexamethasone—asthma	4.67e-05	0.000195	CcSEcCtD
Levomilnacipran—Urticaria—Betamethasone—asthma	4.67e-05	0.000195	CcSEcCtD
Levomilnacipran—Dizziness—Prednisolone—asthma	4.66e-05	0.000194	CcSEcCtD
Levomilnacipran—Asthenia—Triamcinolone—asthma	4.65e-05	0.000194	CcSEcCtD
Levomilnacipran—Body temperature increased—Betamethasone—asthma	4.65e-05	0.000194	CcSEcCtD
Levomilnacipran—Abdominal pain—Betamethasone—asthma	4.65e-05	0.000194	CcSEcCtD
Levomilnacipran—Body temperature increased—Dexamethasone—asthma	4.65e-05	0.000194	CcSEcCtD
Levomilnacipran—Abdominal pain—Dexamethasone—asthma	4.65e-05	0.000194	CcSEcCtD
Levomilnacipran—Asthenia—Methylprednisolone—asthma	4.64e-05	0.000194	CcSEcCtD
Levomilnacipran—Insomnia—Prednisone—asthma	4.63e-05	0.000193	CcSEcCtD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—POMC—asthma	4.62e-05	0.00108	CbGpPWpGaD
Levomilnacipran—Paraesthesia—Prednisone—asthma	4.6e-05	0.000192	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism—CARM1—asthma	4.59e-05	0.00108	CbGpPWpGaD
Levomilnacipran—Pruritus—Triamcinolone—asthma	4.58e-05	0.000191	CcSEcCtD
Levomilnacipran—Pruritus—Methylprednisolone—asthma	4.57e-05	0.000191	CcSEcCtD
Levomilnacipran—Dizziness—Hydrocortisone—asthma	4.55e-05	0.00019	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism—DCN—asthma	4.52e-05	0.00106	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—LTA4H—asthma	4.51e-05	0.00106	CbGpPWpGaD
Levomilnacipran—Dyspepsia—Prednisone—asthma	4.5e-05	0.000188	CcSEcCtD
Levomilnacipran—Decreased appetite—Prednisone—asthma	4.45e-05	0.000186	CcSEcCtD
Levomilnacipran—Rash—Prednisolone—asthma	4.44e-05	0.000185	CcSEcCtD
Levomilnacipran—Dermatitis—Prednisolone—asthma	4.44e-05	0.000185	CcSEcCtD
Levomilnacipran—Diarrhoea—Methylprednisolone—asthma	4.42e-05	0.000185	CcSEcCtD
Levomilnacipran—Fatigue—Prednisone—asthma	4.41e-05	0.000184	CcSEcCtD
Levomilnacipran—Headache—Prednisolone—asthma	4.41e-05	0.000184	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism—ALDH2—asthma	4.4e-05	0.00103	CbGpPWpGaD
Levomilnacipran—Constipation—Prednisone—asthma	4.38e-05	0.000183	CcSEcCtD
Levomilnacipran—Vomiting—Hydrocortisone—asthma	4.37e-05	0.000183	CcSEcCtD
Levomilnacipran—Rash—Hydrocortisone—asthma	4.34e-05	0.000181	CcSEcCtD
Levomilnacipran—Dermatitis—Hydrocortisone—asthma	4.33e-05	0.000181	CcSEcCtD
Levomilnacipran—Headache—Hydrocortisone—asthma	4.31e-05	0.00018	CcSEcCtD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—VEGFA—asthma	4.3e-05	0.00101	CbGpPWpGaD
Levomilnacipran—Dizziness—Triamcinolone—asthma	4.28e-05	0.000179	CcSEcCtD
Levomilnacipran—Dizziness—Methylprednisolone—asthma	4.27e-05	0.000178	CcSEcCtD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—POMC—asthma	4.25e-05	0.000996	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GSTP1—asthma	4.23e-05	0.000992	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—POMC—asthma	4.23e-05	0.000991	CbGpPWpGaD
Levomilnacipran—Asthenia—Dexamethasone—asthma	4.22e-05	0.000176	CcSEcCtD
Levomilnacipran—Asthenia—Betamethasone—asthma	4.22e-05	0.000176	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Prednisone—asthma	4.18e-05	0.000175	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism—GSTT1—asthma	4.18e-05	0.000981	CbGpPWpGaD
Levomilnacipran—Nausea—Prednisolone—asthma	4.18e-05	0.000175	CcSEcCtD
Levomilnacipran—CYP2C8—Metapathway biotransformation—GSTP1—asthma	4.17e-05	0.000979	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—TGFB1—asthma	4.16e-05	0.000975	CbGpPWpGaD
Levomilnacipran—Pruritus—Dexamethasone—asthma	4.16e-05	0.000174	CcSEcCtD
Levomilnacipran—Pruritus—Betamethasone—asthma	4.16e-05	0.000174	CcSEcCtD
Levomilnacipran—Vomiting—Triamcinolone—asthma	4.12e-05	0.000172	CcSEcCtD
Levomilnacipran—Vomiting—Methylprednisolone—asthma	4.11e-05	0.000172	CcSEcCtD
Levomilnacipran—ABCB1—lung—asthma	4.1e-05	0.0132	CbGeAlD
Levomilnacipran—Nausea—Hydrocortisone—asthma	4.09e-05	0.000171	CcSEcCtD
Levomilnacipran—Rash—Triamcinolone—asthma	4.08e-05	0.000171	CcSEcCtD
Levomilnacipran—Dermatitis—Triamcinolone—asthma	4.08e-05	0.00017	CcSEcCtD
Levomilnacipran—Rash—Methylprednisolone—asthma	4.07e-05	0.00017	CcSEcCtD
Levomilnacipran—Dermatitis—Methylprednisolone—asthma	4.07e-05	0.00017	CcSEcCtD
Levomilnacipran—Urticaria—Prednisone—asthma	4.07e-05	0.00017	CcSEcCtD
Levomilnacipran—Headache—Triamcinolone—asthma	4.06e-05	0.000169	CcSEcCtD
Levomilnacipran—Headache—Methylprednisolone—asthma	4.05e-05	0.000169	CcSEcCtD
Levomilnacipran—Abdominal pain—Prednisone—asthma	4.05e-05	0.000169	CcSEcCtD
Levomilnacipran—Body temperature increased—Prednisone—asthma	4.05e-05	0.000169	CcSEcCtD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	4.04e-05	0.000946	CbGpPWpGaD
Levomilnacipran—Diarrhoea—Betamethasone—asthma	4.02e-05	0.000168	CcSEcCtD
Levomilnacipran—Diarrhoea—Dexamethasone—asthma	4.02e-05	0.000168	CcSEcCtD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	3.96e-05	0.00093	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GSTM1—asthma	3.89e-05	0.000912	CbGpPWpGaD
Levomilnacipran—Dizziness—Dexamethasone—asthma	3.89e-05	0.000162	CcSEcCtD
Levomilnacipran—Dizziness—Betamethasone—asthma	3.89e-05	0.000162	CcSEcCtD
Levomilnacipran—SLC6A4—Circadian rythm related genes—PTEN—asthma	3.88e-05	0.000911	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—ALB—asthma	3.86e-05	0.000904	CbGpPWpGaD
Levomilnacipran—Nausea—Triamcinolone—asthma	3.85e-05	0.000161	CcSEcCtD
Levomilnacipran—Nausea—Methylprednisolone—asthma	3.84e-05	0.00016	CcSEcCtD
Levomilnacipran—CYP2C8—Metapathway biotransformation—GSTM1—asthma	3.84e-05	0.000899	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—GSTP1—asthma	3.78e-05	0.000886	CbGpPWpGaD
Levomilnacipran—Hypersensitivity—Prednisone—asthma	3.77e-05	0.000157	CcSEcCtD
Levomilnacipran—Vomiting—Dexamethasone—asthma	3.74e-05	0.000156	CcSEcCtD
Levomilnacipran—Vomiting—Betamethasone—asthma	3.74e-05	0.000156	CcSEcCtD
Levomilnacipran—CYP2C19—Metapathway biotransformation—GSTP1—asthma	3.73e-05	0.000874	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IFNG—asthma	3.71e-05	0.000871	CbGpPWpGaD
Levomilnacipran—Rash—Dexamethasone—asthma	3.7e-05	0.000155	CcSEcCtD
Levomilnacipran—Rash—Betamethasone—asthma	3.7e-05	0.000155	CcSEcCtD
Levomilnacipran—Dermatitis—Betamethasone—asthma	3.7e-05	0.000155	CcSEcCtD
Levomilnacipran—Dermatitis—Dexamethasone—asthma	3.7e-05	0.000155	CcSEcCtD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—asthma	3.68e-05	0.000863	CbGpPWpGaD
Levomilnacipran—Headache—Betamethasone—asthma	3.68e-05	0.000154	CcSEcCtD
Levomilnacipran—Headache—Dexamethasone—asthma	3.68e-05	0.000154	CcSEcCtD
Levomilnacipran—Asthenia—Prednisone—asthma	3.67e-05	0.000153	CcSEcCtD
Levomilnacipran—Pruritus—Prednisone—asthma	3.62e-05	0.000151	CcSEcCtD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ADCY2—asthma	3.59e-05	0.000841	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—TGFB1—asthma	3.58e-05	0.000838	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	3.57e-05	0.000836	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—ALB—asthma	3.56e-05	0.000835	CbGpPWpGaD
Levomilnacipran—Diarrhoea—Prednisone—asthma	3.5e-05	0.000146	CcSEcCtD
Levomilnacipran—Nausea—Betamethasone—asthma	3.49e-05	0.000146	CcSEcCtD
Levomilnacipran—Nausea—Dexamethasone—asthma	3.49e-05	0.000146	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism—NQO1—asthma	3.48e-05	0.000815	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GSTP1—asthma	3.47e-05	0.000815	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—GSTM1—asthma	3.47e-05	0.000814	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	3.46e-05	0.000812	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CXCL8—asthma	3.45e-05	0.000809	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ALDH2—asthma	3.45e-05	0.000808	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—GSTP1—asthma	3.43e-05	0.000804	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	3.43e-05	0.000803	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—GSTM1—asthma	3.42e-05	0.000803	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADCY2—asthma	3.4e-05	0.000798	CbGpPWpGaD
Levomilnacipran—Dizziness—Prednisone—asthma	3.38e-05	0.000141	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.37e-05	0.000791	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL1B—asthma	3.31e-05	0.000777	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL2—asthma	3.3e-05	0.000774	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTT1—asthma	3.28e-05	0.000768	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	3.26e-05	0.000765	CbGpPWpGaD
Levomilnacipran—Vomiting—Prednisone—asthma	3.25e-05	0.000136	CcSEcCtD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	3.24e-05	0.000759	CbGpPWpGaD
Levomilnacipran—Rash—Prednisone—asthma	3.23e-05	0.000135	CcSEcCtD
Levomilnacipran—Dermatitis—Prednisone—asthma	3.22e-05	0.000135	CcSEcCtD
Levomilnacipran—Headache—Prednisone—asthma	3.21e-05	0.000134	CcSEcCtD
Levomilnacipran—CYP2D6—Biological oxidations—GSTM1—asthma	3.19e-05	0.000749	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—asthma	3.17e-05	0.000743	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	3.17e-05	0.000743	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	3.17e-05	0.000743	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	3.17e-05	0.000743	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—GSTM1—asthma	3.15e-05	0.000738	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	3.12e-05	0.000731	CbGpPWpGaD
Levomilnacipran—Nausea—Prednisone—asthma	3.04e-05	0.000127	CcSEcCtD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—asthma	3.02e-05	0.000709	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—HMOX1—asthma	3.02e-05	0.000707	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—asthma	2.97e-05	0.000697	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—asthma	2.94e-05	0.00069	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GSTP1—asthma	2.9e-05	0.00068	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—HMOX1—asthma	2.86e-05	0.00067	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ITPR1—asthma	2.85e-05	0.000669	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	2.83e-05	0.000663	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—asthma	2.83e-05	0.000663	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CAT—asthma	2.82e-05	0.000662	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—VEGFA—asthma	2.8e-05	0.000657	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.78e-05	0.000651	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—POMC—asthma	2.75e-05	0.000645	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—asthma	2.7e-05	0.000633	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.7e-05	0.000632	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GSTM1—asthma	2.66e-05	0.000625	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PLA2G4A—asthma	2.66e-05	0.000625	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	2.6e-05	0.00061	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LTC4S—asthma	2.59e-05	0.000608	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TGFB1—asthma	2.57e-05	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—asthma	2.57e-05	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPP2CA—asthma	2.45e-05	0.000575	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—POMC—asthma	2.45e-05	0.000575	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—IL6—asthma	2.43e-05	0.000569	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.41e-05	0.000564	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TNF—asthma	2.4e-05	0.000563	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LTC4S—asthma	2.31e-05	0.000543	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—asthma	2.3e-05	0.000538	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTP1—asthma	2.27e-05	0.000533	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LTC4S—asthma	2.26e-05	0.00053	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—POMC—asthma	2.26e-05	0.000529	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LTA4H—asthma	2.25e-05	0.000527	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—GSTP1—asthma	2.24e-05	0.000525	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	2.13e-05	0.000499	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LTC4S—asthma	2.13e-05	0.000499	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTM1—asthma	2.09e-05	0.000489	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—GSTM1—asthma	2.06e-05	0.000483	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LTA4H—asthma	2.01e-05	0.00047	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ARG1—asthma	1.97e-05	0.000461	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LTA4H—asthma	1.96e-05	0.000459	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—asthma	1.88e-05	0.000442	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	1.85e-05	0.000434	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LTA4H—asthma	1.85e-05	0.000433	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—asthma	1.81e-05	0.000425	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH7A1—asthma	1.78e-05	0.000417	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	1.76e-05	0.000412	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ARG1—asthma	1.75e-05	0.000411	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—asthma	1.72e-05	0.000403	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ARG1—asthma	1.71e-05	0.000401	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ARG2—asthma	1.7e-05	0.000399	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NOS3—asthma	1.64e-05	0.000385	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ARG1—asthma	1.61e-05	0.000378	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH7A1—asthma	1.59e-05	0.000372	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	1.58e-05	0.00037	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH7A1—asthma	1.55e-05	0.000363	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	1.53e-05	0.000359	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ARG2—asthma	1.52e-05	0.000357	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—asthma	1.5e-05	0.000352	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.49e-05	0.00035	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ARG2—asthma	1.48e-05	0.000348	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—asthma	1.48e-05	0.000346	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH7A1—asthma	1.46e-05	0.000342	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALOX15—asthma	1.41e-05	0.000331	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALOX5AP—asthma	1.41e-05	0.000331	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ARG2—asthma	1.4e-05	0.000328	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LTC4S—asthma	1.39e-05	0.000326	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.38e-05	0.000324	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CHAT—asthma	1.35e-05	0.000316	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.33e-05	0.000313	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.33e-05	0.000311	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTEN—asthma	1.31e-05	0.000307	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.27e-05	0.000298	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALOX5AP—asthma	1.26e-05	0.000295	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALOX15—asthma	1.26e-05	0.000295	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.25e-05	0.000292	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALOX5AP—asthma	1.23e-05	0.000288	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALOX15—asthma	1.23e-05	0.000288	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LTA4H—asthma	1.21e-05	0.000283	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CHAT—asthma	1.2e-05	0.000282	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALOX5—asthma	1.2e-05	0.000281	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.19e-05	0.000278	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CHAT—asthma	1.17e-05	0.000275	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALOX5AP—asthma	1.16e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALOX15—asthma	1.16e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CARM1—asthma	1.15e-05	0.000268	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—DCN—asthma	1.13e-05	0.000265	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CHAT—asthma	1.11e-05	0.000259	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH2—asthma	1.1e-05	0.000257	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALOX5—asthma	1.07e-05	0.000251	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	1.06e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ARG1—asthma	1.05e-05	0.000247	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALOX5—asthma	1.05e-05	0.000245	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTT1—asthma	1.04e-05	0.000245	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CARM1—asthma	1.02e-05	0.00024	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DCN—asthma	1.01e-05	0.000236	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CARM1—asthma	9.98e-06	0.000234	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALOX5—asthma	9.85e-06	0.000231	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DCN—asthma	9.83e-06	0.000231	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH2—asthma	9.8e-06	0.00023	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	9.62e-06	0.000226	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH2—asthma	9.56e-06	0.000224	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH7A1—asthma	9.54e-06	0.000224	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	9.42e-06	0.000221	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CARM1—asthma	9.4e-06	0.00022	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTT1—asthma	9.32e-06	0.000219	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DCN—asthma	9.27e-06	0.000217	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ARG2—asthma	9.14e-06	0.000214	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTT1—asthma	9.1e-06	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH2—asthma	9.01e-06	0.000211	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NQO1—asthma	8.68e-06	0.000203	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	8.59e-06	0.000201	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTT1—asthma	8.57e-06	0.000201	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADCY2—asthma	8.49e-06	0.000199	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.42e-06	0.000197	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—asthma	7.97e-06	0.000187	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NQO1—asthma	7.75e-06	0.000182	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADCY2—asthma	7.58e-06	0.000178	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALOX15—asthma	7.58e-06	0.000178	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALOX5AP—asthma	7.58e-06	0.000178	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NQO1—asthma	7.56e-06	0.000177	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	7.52e-06	0.000176	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADCY2—asthma	7.4e-06	0.000173	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	7.34e-06	0.000172	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTP1—asthma	7.24e-06	0.00017	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CHAT—asthma	7.23e-06	0.000169	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—asthma	7.14e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NQO1—asthma	7.12e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ITPR1—asthma	7.12e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAT—asthma	7.04e-06	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADCY2—asthma	6.97e-06	0.000163	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTM1—asthma	6.65e-06	0.000156	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLA2G4A—asthma	6.65e-06	0.000156	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	6.55e-06	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTP1—asthma	6.46e-06	0.000151	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALOX5—asthma	6.44e-06	0.000151	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—asthma	6.37e-06	0.000149	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ITPR1—asthma	6.36e-06	0.000149	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTP1—asthma	6.31e-06	0.000148	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAT—asthma	6.29e-06	0.000147	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—asthma	6.22e-06	0.000146	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ITPR1—asthma	6.21e-06	0.000145	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CARM1—asthma	6.15e-06	0.000144	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAT—asthma	6.14e-06	0.000144	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPP2CA—asthma	6.13e-06	0.000144	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DCN—asthma	6.06e-06	0.000142	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTP1—asthma	5.94e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTM1—asthma	5.94e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLA2G4A—asthma	5.94e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH2—asthma	5.89e-06	0.000138	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—asthma	5.86e-06	0.000137	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ITPR1—asthma	5.85e-06	0.000137	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTM1—asthma	5.79e-06	0.000136	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLA2G4A—asthma	5.79e-06	0.000136	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAT—asthma	5.78e-06	0.000136	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTT1—asthma	5.61e-06	0.000131	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPP2CA—asthma	5.47e-06	0.000128	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLA2G4A—asthma	5.46e-06	0.000128	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTM1—asthma	5.46e-06	0.000128	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPP2CA—asthma	5.34e-06	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPP2CA—asthma	5.03e-06	0.000118	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—asthma	4.7e-06	0.00011	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NQO1—asthma	4.66e-06	0.000109	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADCY2—asthma	4.56e-06	0.000107	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—asthma	4.29e-06	0.0001	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—asthma	4.2e-06	9.84e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—asthma	4.1e-06	9.61e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—asthma	4.1e-06	9.6e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTP1—asthma	3.89e-06	9.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—asthma	3.86e-06	9.05e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—asthma	3.83e-06	8.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—asthma	3.83e-06	8.97e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ITPR1—asthma	3.82e-06	8.96e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAT—asthma	3.78e-06	8.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—asthma	3.75e-06	8.79e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—asthma	3.73e-06	8.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—asthma	3.66e-06	8.58e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—asthma	3.57e-06	8.37e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLA2G4A—asthma	3.57e-06	8.37e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM1—asthma	3.57e-06	8.37e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—asthma	3.52e-06	8.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—asthma	3.37e-06	7.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—asthma	3.35e-06	7.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPP2CA—asthma	3.29e-06	7.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTEN—asthma	3.27e-06	7.67e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—asthma	3.27e-06	7.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—asthma	3.08e-06	7.22e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTEN—asthma	2.92e-06	6.84e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTEN—asthma	2.85e-06	6.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTEN—asthma	2.68e-06	6.29e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—asthma	2.52e-06	5.92e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—asthma	2.3e-06	5.39e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—asthma	2.2e-06	5.16e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—asthma	2.01e-06	4.72e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTEN—asthma	1.76e-06	4.12e-05	CbGpPWpGaD
